Corrigendum to “Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study” [Eur J Cancer 213 (December) (2024) 115078]

Saved in:

Bibliographic Details
Main Authors:	Azad, Arun (Author) , Fizazi, Karim (Author) , Matsubara, Nobuaki (Author) , Saad, Fred (Author) , De Giorgi, Ugo (Author) , Joung, Jae Young (Author) , Fong, Peter C. C. (Author) , Jones, Robert J. (Author) , Zschäbitz, Stefanie (Author) , Oldenburg, Jan (Author) , Shore, Neal D. (Author) , Dunshee, Curtis (Author) , Carles, Joan (Author) , Fay, Andre P. (Author) , Lin, Xun (Author) , DeAnnuntis, Liza (Author) , Di Santo, Nicola (Author) , Zielinski, Michael A. (Author) , Agarwal, Neeraj (Author)
Format:	Article (Journal)
Language:	English
Published:	January 2026
In:	European journal of cancer Year: 2026, Volume: 232, Pages: 1-2
ISSN:	1879-0852
DOI:	10.1016/j.ejca.2025.116106
Online Access:	Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.ejca.2025.116106 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S095980492500992X
Author Notes:	Arun A. Azad, Karim Fizazi, Nobuaki Matsubara, Fred Saad, Ugo De Giorgi, Jae Young Joung, Peter C.C. Fong, Robert J. Jones, Stefanie Zschäbitz, Jan Oldenburg, Neal D. Shore, Curtis Dunshee, Joan Carles, Andre P. Fay, Xun Lin, Liza DeAnnuntis, Nicola Di Santo, Michael A. Zielinski, Neeraj Agarwal

Description
Item Description:	Online verfügbar: 13. November 2025, Artikelversion: 18. November 2025 Gesehen am 30.01.2026
Physical Description:	Online Resource
ISSN:	1879-0852
DOI:	10.1016/j.ejca.2025.116106

Similar Items